COMP <GO>
INVA vs JNJ // ENTERPRISE SCALE & MARKET CAP
Innoviva Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: INVA 5
— JNJ 4
▲ ENTERPRISE SCALE & MARKET CAP LEADER: JNJ
LAST: $21.31 (+0.90%) • MKT CAP: $1.54B
market-cap
$1.54B
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
market-cap
$662.49B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INVA VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INVA | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.80% | 67.90% | +6.90 | INVA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.70% | 25.50% | -10.80 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.6x | 18.5x | -10.90 | INVA | /valuation <GO> |
| Free Cash Flow Yield | 12.72% | 2.97% | +9.75 | INVA | /fcf-yield <GO> |
| Operating Margin | 39.80% | 34.70% | +5.10 | INVA | /operating-margins <GO> |
| Net Profit Margin | — | 28.50% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 14.70% | 6.00% | +8.70 | INVA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.59 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.7 | 62.1 | -7.40 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $1.54B | $662.49B | -$660.95B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INVA REV | JNJ REV | INVA GROSS % | JNJ GROSS % | INVA FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $411.3M | $94.19B | 74.8% | 67.9% | $195.8M | $19.70B |
| FY 2024 | $358.7M | $88.82B | 82.6% | 69.1% | $188.4M | $19.84B |
| FY 2023 | $310.5M | $85.16B | — | — | $141.1M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INVA // BETA —
JNJ // BETA 1.08